Fig. 4From: Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatmentRelease profiles of MBZ from CS-FA-MBZ nanoparticles at pH = 2.2, 5.5, 6.8, and 7.4. Data are expressed as mean ± SD (n = 3)Back to article page